Skip to content
The Researcher's Lens

When the Bench Meets AI: New Possibilities for Biological Discovery

The most exciting promise of AI lies in its ability to serve as a bioinformatics partner. Computational analysis remains one of the greatest bottlenecks in molecular cancer biology.

Advaitha MadireddyWritten November 2026 · 3 min read

Every time a cell divides, it must faithfully duplicate billions of DNA bases while preserving the integrity of the genome. Although this process occurs countless times throughout life, DNA replication is far from perfect. Replication forks encounter obstacles, DNA becomes damaged, and errors accumulate over time. Understanding how cells respond to these challenges, and how replication stress contributes to genome instability and cancer development, lies at the center of my laboratory's research.

Answering these questions increasingly requires us to navigate enormous amounts of biological data. Modern experimental approaches allow us to measure events at the level of individual DNA molecules, entire genomes, and complex cellular populations simultaneously. The challenge is no longer generating data. It is integrating, interpreting, and extracting meaningful biological insight from it.


This is where artificial intelligence has begun to transform the way we work. In my lab, AI has become more than a simple productivity tool. It serves as a scientific partner that can help organize information, develop computational approaches, identify assumptions, and translate broad biological questions into testable hypotheses. Its greatest value emerges when it is paired with subject matter expertise and a clearly defined scientific objective.

Equally important, AI can accelerate the development of analytical workflows and computational tools. Tasks that once required extensive coding experience or substantial time investment can often be explored much more rapidly through interactive collaboration with AI systems. This creates opportunities to pursue scientific questions that may have previously been impractical or entirely out of reach. What once appeared impossible can quickly become achievable, opening new avenues for discovery and accelerating the pace of biological research.


Using these tools effectively requires caution and scientific judgment. AI can generate highly plausible explanations, analyses, and code, yet its outputs are not always correct. As biological experts, it remains our responsibility to verify sources, check calculations, and evaluate recommendations through the lens of our experimental knowledge and expertise. A critical aspect of scientific research is the protection of unpublished data, discoveries, and ideas. This reality must guide decisions about how and where AI technologies are deployed, ensuring that innovation is advanced without compromising scientific integrity or intellectual property.

For my lab, the most exciting promise of AI lies in its ability to serve as a bioinformatics partner. Computational analysis capabilities, or the lack thereof, remain one of the greatest bottlenecks in molecular cancer biology. We now generate genomic data at an unprecedented rate, yet extracting meaningful biological insight from those datasets often lags behind. AI has the potential to fundamentally change that equation.

By making powerful computational approaches more accessible, it allows laboratories like mine to tackle increasingly complex questions without being limited by traditional analytical barriers. This new era of AI brings with it remarkable possibilities, turning obstacles that once constrained discovery into opportunities for innovation. By expanding our ability to interpret complex biological data, AI may help accelerate scientific discovery at a pace and scale that would have seemed unimaginable just a few years ago.

Advaitha MadireddyWritten November 2026